Specialty pharmaceutical company that manufactures generic, brand and biologic drugs
H.R.2029 - Consolidated Appropriations Act, 2016
Lobbied on issues related to abuse deterrent formulations of drugs and prescription drug abuse
FDA proposed rule on generic drug labels 
S. 484 and HR 1353 PATIENTS Act of 2015 
Senate HELP working group on Innovation for Healthier Americans
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LOPER CONSULTING LLC
4551 32nd Road North, Arlington, VA, 22207, US
GINGER LOPER (Special Assistant to the President 2002-2005)
Special Assistant to the President 2002-2005